According to The REMBRANT Database, some human gliomas exhibit a highly aggressive, low Egln3-expression phenotype (i.e. >2-fold decreases in Egln3 relative to basal brain levels), analogous to Hu- and Rt-gliomas in which Egln3 protein was not detected. The gene discussed is EGLN3; the disease is central nervous system cancer.